Angel Veloso, MD
Gastroenterology · Coral Gables, FLNPI 1477589505
Payments from drug & device makers
Across 612 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- AbbVie$2K
- Ardelyx, Inc.$720
- Sanofi$617
- Ironwood Pharmaceuticals, Inc$518
- Cumberland Pharmaceuticals, Inc.$449
- plus $3K from 30 others
What the payments were for
- Consulting fees$460%
- Food & beverage$9,64499%
- Education$320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 175 | $2,000 |
| AbbVie(2 entities) | 131 | $1,971 |
| Ardelyx, Inc. | 50 | $720 |
| Sanofi | 19 | $617 |
| Ironwood Pharmaceuticals, Inc | 33 | $518 |
| Cumberland Pharmaceuticals, Inc. | 9 | $449 |
| Redhill Biopharma Inc. | 32 | $442 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $373 |
| Nestle Healthcare Nutrition Inc. | 24 | $308 |
| Intercept Pharmaceuticals, Inc. | 13 | $290 |
| Johnson & Johnson | 16 | $254 |
| Phathom Pharmaceuticals, Inc. | 12 | $217 |
| Braintree Laboratories, Inc. | 12 | $199 |
| Novo Nordisk | 3 | $172 |
| Pfizer | 9 | $153 |
| Gilead | 7 | $132 |
| Axonics, Inc. | 2 | $123 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| Bristol Myers Squibb | 5 | $93 |
| Aimmune Therapeutics, Inc. | 5 | $77 |
| Evoke Pharma, Inc. | 4 | $69 |
| Exact Sciences | 3 | $62 |
| Merck | 3 | $43 |
| Lilly USA, LLC | 2 | $43 |
| Romark Laboratories, LC | 2 | $42 |
| Fresenius Kabi USA, LLC | 1 | $35 |
| Shionogi Inc | 2 | $34 |
| Medtronic | 1 | $31 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Vivus LLC | 1 | $18 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kristalose$312
- DUPIXENT$253
- Wegovy$122
- Axonics$108
How this compares
$9,722 in reported general payments places this provider in the 70th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZenpepLipase/Protease/Amylase | 57 | $133,451 |
| XifaxanRifaximin | 43 | $110,352 |
| LinzessLinaclotide | 111 | $64,795 |
| TrulancePlecanatide | 101 | $63,729 |
| CreonLipase/Protease/Amylase | 38 | $55,647 |
| Famotidine | 2,650 | $49,312 |
| IbsrelaTenapanor Hcl | 25 | $44,108 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 232 | $13,893 |
| VoqueznaVonoprazan Fumarate | 12 | $12,108 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 52 | $8,929 |
| Megestrol Acetate | 22 | $5,892 |
| Dexlansoprazole DrDexlansoprazole | 48 | $5,738 |
| Pantoprazole Sodium | 904 | $5,478 |
| CholestyramineCholestyramine (With Sugar) | 76 | $4,434 |
| Ursodiol | 34 | $4,183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $2,000 | $174,081144 claims |
| Aimmune Therapeutics, Inc.Zenpep | $77 | $133,45157 claims |
| AbbVieLinzess, Creon | $1,971 | $120,442149 claims |
| Ardelyx, Inc.Ibsrela | $720 | $44,10825 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $217 | $12,10812 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $15 | $8,92952 claims |
| Braintree Laboratories, Inc.Suflave | $199 | $1,33511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Coral Gables
- Christian AndradeCoral Gables$1.1M
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.